(MORN) Morningstar - Ratings and Ratios
Data, Analytics, Platforms, Research, Ratings
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.55% |
| Yield on Cost 5y | 1.53% |
| Yield CAGR 5y | 17.80% |
| Payout Consistency | 96.1% |
| Payout Ratio | 18.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 23.1% |
| Value at Risk 5%th | 36.0% |
| Relative Tail Risk | -5.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.54 |
| Alpha | -48.68 |
| CAGR/Max DD | -0.07 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.431 |
| Beta | 0.830 |
| Beta Downside | 0.894 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.82% |
| Mean DD | 13.60% |
| Median DD | 9.38% |
Description: MORN Morningstar January 02, 2026
Morningstar, Inc. (NASDAQ:MORN) delivers independent investment research and data services across North America, Europe, Asia-Pacific and other global markets through five operating segments: Data & Analytics, PitchBook, Wealth, Credit, and Retirement. Its product suite spans subscription-based platforms such as Morningstar Direct and Advisor Workstation, managed-investment vehicles (mutual funds, ETFs, model portfolios), private-capital intelligence via PitchBook, ESG ratings through Sustainalytics, and structured-finance analytics via DBRS.
Key recent metrics show the company generated approximately $1.1 billion in revenue for FY 2023, with subscription revenue representing roughly 70 % of total sales and posting a year-over-year growth rate of 9 %. The PitchBook segment has been expanding at an estimated 15 % CAGR, reflecting broader private-market fundraising activity, while ESG data demand has risen in line with a 12 % increase in global sustainable-investment assets under management. Macro-level drivers include rising interest-rate volatility (boosting credit-analytics usage) and continued regulatory emphasis on transparency in private-equity disclosures.
For a deeper quantitative view, you may want to explore ValueRay’s analyst platform.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (376.0m TTM) > 0 and > 6% of Revenue (6% = 143.7m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA -1.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 1.41% (prev 5.71%; Δ -4.30pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 539.1m > Net Income 376.0m (YES >=105%, WARN >=100%) |
| Net Debt (568.4m) to EBITDA (729.4m) ratio: 0.78 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.04 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (42.6m) change vs 12m ago -1.39% (target <= -2.0% for YES) |
| Gross Margin 60.93% (prev 60.91%; Δ 0.02pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 67.25% (prev 62.33%; Δ 4.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 13.69 (EBITDA TTM 729.4m / Interest Expense TTM 39.3m) >= 6 (WARN >= 3) |
Altman Z'' 4.06
| (A) 0.01 = (Total Current Assets 979.2m - Total Current Liabilities 945.5m) / Total Assets 3.56b |
| (B) 0.59 = Retained Earnings (Balance) 2.11b / Total Assets 3.56b |
| (C) 0.15 = EBIT TTM 538.2m / Avg Total Assets 3.56b |
| (D) 1.00 = Book Value of Equity 2.04b / Total Liabilities 2.04b |
| Total Rating: 4.06 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 84.24
| 1. Piotroski 7.0pt |
| 2. FCF Yield 4.10% |
| 3. FCF Margin 16.45% |
| 4. Debt/Equity 0.69 |
| 5. Debt/Ebitda 0.78 |
| 6. ROIC - WACC (= 8.68)% |
| 7. RoE 23.66% |
| 8. Rev. Trend 98.34% |
| 9. EPS Trend 31.33% |
What is the price of MORN shares?
Over the past week, the price has changed by +3.04%, over one month by +1.04%, over three months by -4.22% and over the past year by -30.86%.
Is MORN a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MORN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 278.3 | 28.4% |
| Analysts Target Price | 278.3 | 28.4% |
| ValueRay Target Price | 207.5 | -4.3% |
MORN Fundamental Data Overview January 08, 2026
P/E Forward = 19.1205
P/S = 3.7968
P/B = 5.8591
Beta = 1.079
Revenue TTM = 2.40b USD
EBIT TTM = 538.2m USD
EBITDA TTM = 729.4m USD
Long Term Debt = 848.9m USD (from longTermDebt, last quarter)
Short Term Debt = 39.9m USD (from shortTermDebt, last quarter)
Debt = 1.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 568.4m USD (from netDebt column, last quarter)
Enterprise Value = 9.62b USD (9.09b + Debt 1.04b - CCE 514.5m)
Interest Coverage Ratio = 13.69 (Ebit TTM 538.2m / Interest Expense TTM 39.3m)
EV/FCF = 24.42x (Enterprise Value 9.62b / FCF TTM 394.1m)
FCF Yield = 4.10% (FCF TTM 394.1m / Enterprise Value 9.62b)
FCF Margin = 16.45% (FCF TTM 394.1m / Revenue TTM 2.40b)
Net Margin = 15.70% (Net Income TTM 376.0m / Revenue TTM 2.40b)
Gross Margin = 60.93% ((Revenue TTM 2.40b - Cost of Revenue TTM 935.9m) / Revenue TTM)
Gross Margin QoQ = 60.85% (prev 61.89%)
Tobins Q-Ratio = 2.70 (Enterprise Value 9.62b / Total Assets 3.56b)
Interest Expense / Debt = 0.90% (Interest Expense 9.40m / Debt 1.04b)
Taxrate = 25.53% (31.4m / 123.0m)
NOPAT = 400.8m (EBIT 538.2m * (1 - 25.53%))
Current Ratio = 1.04 (Total Current Assets 979.2m / Total Current Liabilities 945.5m)
Debt / Equity = 0.69 (Debt 1.04b / totalStockholderEquity, last quarter 1.51b)
Debt / EBITDA = 0.78 (Net Debt 568.4m / EBITDA 729.4m)
Debt / FCF = 1.44 (Net Debt 568.4m / FCF TTM 394.1m)
Total Stockholder Equity = 1.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.56% (Net Income 376.0m / Total Assets 3.56b)
RoE = 23.66% (Net Income TTM 376.0m / Total Stockholder Equity 1.59b)
RoCE = 22.08% (EBIT 538.2m / Capital Employed (Equity 1.59b + L.T.Debt 848.9m))
RoIC = 16.79% (NOPAT 400.8m / Invested Capital 2.39b)
WACC = 8.12% (E(9.09b)/V(10.14b) * Re(8.97%) + D(1.04b)/V(10.14b) * Rd(0.90%) * (1-Tc(0.26)))
Discount Rate = 8.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.47%
[DCF Debug] Terminal Value 78.74% ; FCFF base≈414.0m ; Y1≈445.8m ; Y5≈547.2m
Fair Price DCF = 211.8 (EV 9.28b - Net Debt 568.4m = Equity 8.71b / Shares 41.1m; r=8.12% [WACC]; 5y FCF grow 8.65% → 2.90% )
EPS Correlation: 31.33 | EPS CAGR: -25.21% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.34 | Revenue CAGR: 8.03% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.51 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=10.79 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+14.8% | Growth Revenue=+7.5%
Additional Sources for MORN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle